Multifocal drug-resistant epilepsy in a patient with a newly discovered mutation in tuberous sclerosis complex 1 gene treated by deep brain stimulation in the anterior thalamic nucleus

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in the tumor suppressor genes TSC1 or TSC2. TSC is characterized by the formation of multiple tumors in various organs. The most common neurological manifestation of the disorder is epilepsy present in 79–90% of c...

Full description

Bibliographic Details
Main Authors: Michał Sobstyl, Paweł Jezierski, Magdalena Konopko, Angelika Stapińska-Syniec
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Epilepsy & Behavior Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589986423000552
_version_ 1797281167688335360
author Michał Sobstyl
Paweł Jezierski
Magdalena Konopko
Angelika Stapińska-Syniec
author_facet Michał Sobstyl
Paweł Jezierski
Magdalena Konopko
Angelika Stapińska-Syniec
author_sort Michał Sobstyl
collection DOAJ
description Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in the tumor suppressor genes TSC1 or TSC2. TSC is characterized by the formation of multiple tumors in various organs. The most common neurological manifestation of the disorder is epilepsy present in 79–90% of cases. At least one-third of TSC patients develop drug-resistant epilepsy (DRE) which remains a great challenge for clinicians. Neuromodulation is an option in cases of multifocal epilepsy, epilepsy originating in eloquent areas, or the inability to identify the ictal onset zone. Deep brain stimulation of the anterior thalamic nucleus (ANT-DBS) may be used in the treatment of multifocal DRE. Here, we present a case of a patient with multifocal DRE caused by TSC, who was treated with ANT-DBS. A follow-up period of eight months showed that the patient's multifocal DRE was successfully treated by ANT-DBS.
first_indexed 2024-03-07T16:52:43Z
format Article
id doaj.art-08599d7c31b143d99dc683a278dc3836
institution Directory Open Access Journal
issn 2589-9864
language English
last_indexed 2024-03-07T16:52:43Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Epilepsy & Behavior Reports
spelling doaj.art-08599d7c31b143d99dc683a278dc38362024-03-03T04:30:04ZengElsevierEpilepsy & Behavior Reports2589-98642024-01-0125100637Multifocal drug-resistant epilepsy in a patient with a newly discovered mutation in tuberous sclerosis complex 1 gene treated by deep brain stimulation in the anterior thalamic nucleusMichał Sobstyl0Paweł Jezierski1Magdalena Konopko2Angelika Stapińska-Syniec3Department of Neurosurgery, Institute of Psychiatry and Neurology, Sobieskiego 9 Street 02-957, Warsaw, Poland1st Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego 9 Street, 02-957 Warsaw, Poland1st Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego 9 Street, 02-957 Warsaw, PolandDepartment of Neurosurgery, Institute of Psychiatry and Neurology, Sobieskiego 9 Street 02-957, Warsaw, Poland; Corresponding author.Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in the tumor suppressor genes TSC1 or TSC2. TSC is characterized by the formation of multiple tumors in various organs. The most common neurological manifestation of the disorder is epilepsy present in 79–90% of cases. At least one-third of TSC patients develop drug-resistant epilepsy (DRE) which remains a great challenge for clinicians. Neuromodulation is an option in cases of multifocal epilepsy, epilepsy originating in eloquent areas, or the inability to identify the ictal onset zone. Deep brain stimulation of the anterior thalamic nucleus (ANT-DBS) may be used in the treatment of multifocal DRE. Here, we present a case of a patient with multifocal DRE caused by TSC, who was treated with ANT-DBS. A follow-up period of eight months showed that the patient's multifocal DRE was successfully treated by ANT-DBS.http://www.sciencedirect.com/science/article/pii/S2589986423000552Multifocal drug-resistant epilepsyAnterior nucleus of the thalamusDeep brain stimulationTuberous sclerosis complex
spellingShingle Michał Sobstyl
Paweł Jezierski
Magdalena Konopko
Angelika Stapińska-Syniec
Multifocal drug-resistant epilepsy in a patient with a newly discovered mutation in tuberous sclerosis complex 1 gene treated by deep brain stimulation in the anterior thalamic nucleus
Epilepsy & Behavior Reports
Multifocal drug-resistant epilepsy
Anterior nucleus of the thalamus
Deep brain stimulation
Tuberous sclerosis complex
title Multifocal drug-resistant epilepsy in a patient with a newly discovered mutation in tuberous sclerosis complex 1 gene treated by deep brain stimulation in the anterior thalamic nucleus
title_full Multifocal drug-resistant epilepsy in a patient with a newly discovered mutation in tuberous sclerosis complex 1 gene treated by deep brain stimulation in the anterior thalamic nucleus
title_fullStr Multifocal drug-resistant epilepsy in a patient with a newly discovered mutation in tuberous sclerosis complex 1 gene treated by deep brain stimulation in the anterior thalamic nucleus
title_full_unstemmed Multifocal drug-resistant epilepsy in a patient with a newly discovered mutation in tuberous sclerosis complex 1 gene treated by deep brain stimulation in the anterior thalamic nucleus
title_short Multifocal drug-resistant epilepsy in a patient with a newly discovered mutation in tuberous sclerosis complex 1 gene treated by deep brain stimulation in the anterior thalamic nucleus
title_sort multifocal drug resistant epilepsy in a patient with a newly discovered mutation in tuberous sclerosis complex 1 gene treated by deep brain stimulation in the anterior thalamic nucleus
topic Multifocal drug-resistant epilepsy
Anterior nucleus of the thalamus
Deep brain stimulation
Tuberous sclerosis complex
url http://www.sciencedirect.com/science/article/pii/S2589986423000552
work_keys_str_mv AT michałsobstyl multifocaldrugresistantepilepsyinapatientwithanewlydiscoveredmutationintuberoussclerosiscomplex1genetreatedbydeepbrainstimulationintheanteriorthalamicnucleus
AT pawełjezierski multifocaldrugresistantepilepsyinapatientwithanewlydiscoveredmutationintuberoussclerosiscomplex1genetreatedbydeepbrainstimulationintheanteriorthalamicnucleus
AT magdalenakonopko multifocaldrugresistantepilepsyinapatientwithanewlydiscoveredmutationintuberoussclerosiscomplex1genetreatedbydeepbrainstimulationintheanteriorthalamicnucleus
AT angelikastapinskasyniec multifocaldrugresistantepilepsyinapatientwithanewlydiscoveredmutationintuberoussclerosiscomplex1genetreatedbydeepbrainstimulationintheanteriorthalamicnucleus